SG11201800675PA - Composition containing cyclic dipeptide and sweetening agent - Google Patents

Composition containing cyclic dipeptide and sweetening agent

Info

Publication number
SG11201800675PA
SG11201800675PA SG11201800675PA SG11201800675PA SG11201800675PA SG 11201800675P A SG11201800675P A SG 11201800675PA SG 11201800675P A SG11201800675P A SG 11201800675PA SG 11201800675P A SG11201800675P A SG 11201800675PA SG 11201800675P A SG11201800675P A SG 11201800675PA
Authority
SG
Singapore
Prior art keywords
composition containing
sweetening agent
containing cyclic
cyclic dipeptide
dipeptide
Prior art date
Application number
SG11201800675PA
Other languages
English (en)
Inventor
Toshihide Suzuki
Natsumi Hiraki
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of SG11201800675PA publication Critical patent/SG11201800675PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Seasonings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
SG11201800675PA 2015-07-27 2016-07-26 Composition containing cyclic dipeptide and sweetening agent SG11201800675PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015147652 2015-07-27
PCT/JP2016/071817 WO2017018404A1 (ja) 2015-07-27 2016-07-26 環状ジペプチド及び甘味料を含有する組成物

Publications (1)

Publication Number Publication Date
SG11201800675PA true SG11201800675PA (en) 2018-02-27

Family

ID=57885678

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201912392SA SG10201912392SA (en) 2015-07-27 2016-07-26 Composition containing cyclic dipeptide and sweetening agent
SG11201800675PA SG11201800675PA (en) 2015-07-27 2016-07-26 Composition containing cyclic dipeptide and sweetening agent

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10201912392SA SG10201912392SA (en) 2015-07-27 2016-07-26 Composition containing cyclic dipeptide and sweetening agent

Country Status (10)

Country Link
US (1) US11219663B2 (ja)
EP (1) EP3329928A4 (ja)
JP (1) JP6777632B2 (ja)
KR (1) KR20180030915A (ja)
CN (1) CN107847545B (ja)
AU (1) AU2016299590B2 (ja)
HK (1) HK1250630A1 (ja)
SG (2) SG10201912392SA (ja)
TW (1) TWI744240B (ja)
WO (1) WO2017018404A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020218381A1 (ja) * 2019-04-26 2020-10-29 サントリーホールディングス株式会社 Ｇｌｐ－１分泌促進用組成物
JPWO2020218382A1 (ja) * 2019-04-26 2020-10-29
SG11202111838SA (en) 2019-04-26 2021-11-29 Suntory Holdings Ltd Glp-1 secretion-promoting composition
CN113747921A (zh) * 2019-04-26 2021-12-03 三得利控股株式会社 Glp-1分泌促进用组合物

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5426347A (en) * 1977-07-27 1979-02-27 Sugiyama Sangyo Kagaku Kenk Extracting of soy bean protein
IE65900B1 (en) 1988-10-15 1995-11-29 Satake Eng Co Ltd Apparatus for evaluating quality of raw coffee beans
AU784422B2 (en) * 2000-02-01 2006-03-30 Stevia Aps A substance for the use in a dietary supplementation or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome
US20030059514A1 (en) * 2001-09-10 2003-03-27 Villagran Francisco Valentino Compositions comprising soy protein and processes of their preparation
JP2003252896A (ja) 2002-02-26 2003-09-10 Toyohashi University Of Technology 高温高圧水を用いた環状ペプチドの合成方法
US20070128687A1 (en) 2003-11-28 2007-06-07 Hajime Ikeda Process for producing dipeptides
JP4605631B2 (ja) 2004-01-23 2011-01-05 カルピス株式会社 アンジオテンシン変換酵素阻害剤
KR101175608B1 (ko) 2004-12-08 2012-08-22 다카사고 고료 고교 가부시키가이샤 효소 처리 차류 추출액, 효소 처리 차류 내츄럴 아로마 및 효소 처리 차류 내츄럴 아로마 농축 추출액의 제조방법, 및 이에 의해 수득되는 효소 처리 차류 추출액, 효소 처리 차류 내츄럴 아로마 및 효소 처리 차류 내츄럴 아로마 농축추출액
WO2006116814A1 (en) * 2005-05-02 2006-11-09 Vanadis Bioscience Ltd Composition and uses thereof
US8945652B2 (en) * 2005-11-23 2015-02-03 The Coca-Cola Company High-potency sweetener for weight management and compositions sweetened therewith
US20080107787A1 (en) * 2006-11-02 2008-05-08 The Coca-Cola Company Anti-Diabetic Composition with High-Potency Sweetener
JP2010138143A (ja) * 2008-12-15 2010-06-24 Hokkaido Univ Ｇｌｐ−１分泌促進剤
JP5576653B2 (ja) 2008-12-26 2014-08-20 サントリー食品インターナショナル株式会社 環状ジペプチド含有飲料
CN101461441A (zh) 2008-12-29 2009-06-24 浙江工商大学 茶叶蛋白的双酶提取法
CN102361560A (zh) * 2008-12-31 2012-02-22 索莱有限责任公司 具有提高的cck释放能力的蛋白质水解产物组合物
US9901551B2 (en) * 2009-04-20 2018-02-27 Ambra Bioscience Llc Chemosensory receptor ligand-based therapies
SG178211A1 (en) 2009-12-25 2012-03-29 Suntory Holdings Ltd Extracts and beverages containing 2, 5-piperazinedione, 3, 6-bis (phenylmethyl) -, (3s, 6s) -
AU2010334164B2 (en) 2009-12-25 2014-09-11 Suntory Beverage & Food Asia Pte. Ltd. Learning motivation improvers
JP4901950B2 (ja) 2009-12-25 2012-03-21 サントリーホールディングス株式会社 ２，５−ピペラジンジオン，３，６−ビス（フェニルメチル）−，（３ｓ，６ｓ）−を含有する酸性飲食品
EA023932B1 (ru) 2010-09-07 2016-07-29 Ампио Фармасьютикалз, Инк. Лечение заболеваний, связанных с гиперпроницаемостью сосудов
CN104220875A (zh) * 2010-10-19 2014-12-17 埃尔舍利克斯治疗公司 基于化学感应受体配体的治疗
CN103314000B (zh) * 2010-11-19 2018-07-27 嘉吉公司 使用具有大孔中性吸附树脂的吸附-脱附色谱用于富集衍生自甜叶菊的糖苷组合物中的新蛇菊苷b和/或新蛇菊苷d的方法
WO2012111820A1 (ja) 2011-02-17 2012-08-23 サントリーホールディングス株式会社 茶飲料用原料の製造方法
EP4012041A1 (en) 2012-05-22 2022-06-15 PureCircle SDN BHD High-purity steviol glycosides
JP5456876B1 (ja) 2012-12-25 2014-04-02 ゼライス株式会社 環状ジペプチドの製造方法
WO2014200000A1 (ja) * 2013-06-10 2014-12-18 サントリーホールディングス株式会社 ジケトピペラジンを含有する植物エキス及びその製造方法
CN104817615A (zh) 2014-01-30 2015-08-05 陈光健 寡肽cd05及其制备方法和应用
WO2015194035A1 (ja) * 2014-06-20 2015-12-23 サントリーホールディングス株式会社 環状ジペプチド含有組成物
AU2014397560A1 (en) 2014-06-20 2017-01-05 Suntory Holdings Limited Composition with high content of cyclic dipeptide
CA2904493A1 (en) 2014-06-20 2015-12-20 Toshihide Suzuki Uric acid-lowering agent
WO2015194447A1 (ja) 2014-06-20 2015-12-23 サントリーホールディングス株式会社 糖代謝改善剤

Also Published As

Publication number Publication date
WO2017018404A1 (ja) 2017-02-02
HK1250630A1 (zh) 2019-01-11
AU2016299590B2 (en) 2022-09-01
US20180214508A1 (en) 2018-08-02
KR20180030915A (ko) 2018-03-26
CN107847545B (zh) 2022-01-04
AU2016299590A1 (en) 2018-02-22
TWI744240B (zh) 2021-11-01
TW201717988A (zh) 2017-06-01
US11219663B2 (en) 2022-01-11
EP3329928A4 (en) 2019-05-01
EP3329928A1 (en) 2018-06-06
SG10201912392SA (en) 2020-02-27
CN107847545A (zh) 2018-03-27
JP6777632B2 (ja) 2020-10-28
JPWO2017018404A1 (ja) 2018-05-17

Similar Documents

Publication Publication Date Title
IL262321A (en) Preparations and methods for selective protein expression
ZA201706256B (en) Hemostatic composition and hemostatic device (variants)
PL3228648T3 (pl) Kopoliwęglan i zawierające go kompozycje
HK1250925A1 (zh) 包含依魯替尼的組合物
PL3269257T3 (pl) Kompozycja słodzika i żywność ją zawierająca
PL3048127T3 (pl) Kopoliwęglan i zawierająca go kompozycja
HK1231330A1 (zh) 高含有環狀二肽的組合物
PL3067379T3 (pl) Kopoliwęglan i zawierająca go kompozycja
HK1254978A1 (zh) 含萊鮑迪甙d的甜味劑組合物
HK1250630A1 (zh) 含有環狀二肽及甜味劑的組合物
IL284792A (en) Peptide derivative - DEPDC1 and a component containing it
HK1258374A1 (zh) 止血組合物和使用止血組合物的止血方法
HK1250915A1 (zh) 組合物和其用途
PL3050908T3 (pl) Kopoliwęglan i zawierająca go kompozycja
HK1250726A1 (zh) 含有氨基酸及環狀二肽的組合物
HK1247220A1 (zh) 環狀甘丙肽類似物及其用途
IL251236B (en) Preparations containing glycosaminoglycans and proteins and their uses
IL250215A0 (en) A peptide derived from cdca1 and a component containing it
PL3307080T3 (pl) Środek słodzący oraz jego zastosowanie
IL250235A0 (en) A peptide derived from urlc10 and a component containing it
PL3050909T3 (pl) Kopoliwęglan i obejmująca go kompozycja
GB201504273D0 (en) Overhood seal and use thereof